Pushing the boundaries of neuroscience with ge healthcare's signa magnus

Chicago--(business wire)--ge healthcare (nasdaq: gehc) today unveiled signa magnus, an fda 510(k) pending head-only magnetic resonance (mr) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body mr systems. neuroscience, particularly in the study of psychiatric diseases and neurological disorders such as alzheimer's, has been constrained by technological and biological limitations, leaving many aspects of th.
GEHC Ratings Summary
GEHC Quant Ranking